Medtronic Names Geoff Martha Executive Vice President and President, Restorative Therapies Group
June 25 2015 - 9:10AM
Martha Succeeds
Christopher J. O'Connell;
Bill Burke Named Medtronic Chief Integration
Officer
DUBLIN - June 25, 2015 -
Medtronic plc (NYSE: MDT) announced today that it has named Geoff
Martha as executive vice president and president, Medtronic
Restorative Therapies Group (RTG), effective
immediately. Martha will replace Christopher J.
O'Connell, who was selected to become chief executive officer of a
public company.
"Chris has passionately served Medtronic for the
past 21 years in various leadership roles," said Omar Ishrak,
Medtronic chairman and chief executive officer. "I know I
speak for all of Medtronic's employees in wishing him the best in
this new phase of his career."
"We are pleased to name Geoff Martha as the new
leader for the Restorative Therapies Group," said Ishrak. "In
his time at Medtronic, Geoff has demonstrated his leadership
capacity in architecting and driving our three-pillared global
strategy around New Therapies, Economic Value and Globalization, as
well as leading our effort to acquire and integrate Covidien, the
largest acquisition in Medtronic's history. I know Geoff will
provide innovative and effective leadership for the RTG team as we
continue to expand and grow our impact for those people around the
world who could benefit from our restorative therapies."
"I'm excited to lead this innovative group of
Medtronic professionals who are committed to ensuring that we
provide physicians and patients the technologies and services that
will allow people with chronic diseases to live their lives to the
fullest," said Martha. "I particularly look forward to
partnering with customers around the world to ensure we are
delivering solutions that meaningfully impact their practices and
the patients they serve. Medtronic has a tremendous capacity
to innovate, and I'm looking forward to leading this team to spur
new levels of ingenuity, growth and performance."
Martha joined Medtronic in 2011 and currently
serves as sr. vice president of Corporate Strategy & Business
Development, Global Communications and Medtronic
Philanthropy. He also serves as the chief integration officer
for the Covidien integration. In these roles, he has a broad
understanding of Medtronic strategies and operations around the
world.
Prior to joining Medtronic, Martha served as
managing director of Business Development at GE Healthcare, where
he was responsible for global business development efforts,
including acquisitions, divestitures, joint ventures and equity
investments. In his 19-year career with GE, Martha held
several leadership roles in business leadership, corporate
development, strategic marketing, and sales management.
Bill Burke Named Chief
Integration Officer
Medtronic also announced today that Bill Burke has been named
Medtronic's chief integration officer for the Covidien acquisition,
effective immediately. Burke will succeed Geoff Martha and
will reporting into Omar Ishrak. Burke currently serves as
the lead deputy to Martha on all Covidien integration efforts and
serves as the principal operating officer for the Integration
Management Office.
"No one is more prepared to step into this role
than Bill Burke," said Ishrak. "His background and knowledge
as a leader within Covidien up to and through the acquisition and
his demonstrated leadership presence and actions on the integration
thus far make him the ideal choice to lead this critical
effort."
Prior to the Covidien acquisition, Burke served as
Covidien's chief financial officer for Europe and in other finance
and business development leadership roles over his 21-year career
at Covidien.
About the Restorative Therapies
Group
The Restorative Therapies Group (RTG) provides innovative, life
changing restorative therapies and services to meet the needs of
millions of people worldwide who suffer from a wide range of
chronic medical conditions. The Group is comprised of
Medtronic's Spine, Neuromodulation, Surgical Technologies, and
Neurovascular Businesses and accounts for approximately $7 billion
in annual revenues.
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin,
Ireland, is the global leader in medical technology - alleviating
pain, restoring health and extending life for millions of people
around the world.
Any forward-looking statements
are subject to risks and uncertainties such as those described in
Medtronic's periodic reports on file with the Securities and
Exchange Commission. Actual results may differ materially from
anticipated results.
-end-
Contacts:
Cindy Resman
Public Relations
+1-763-505-0291
Jeff Warren
Investor Relations
+1-763-505-2696
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Medtronic plc via Globenewswire
HUG#1931402
Medtronic (NYSE:MDT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From Sep 2023 to Sep 2024